162 related articles for article (PubMed ID: 11812159)
41. [Expression of COX-1 and COX-2 and gastrointestinal diseases].
Tsujii M; Kawano S; Tsuji S; Takei Y; Sawaoka H; Omae A; Murata H; Kawai N; Iijima H; Hori M
Nihon Naika Gakkai Zasshi; 1998 Oct; 87(10):2114-21. PubMed ID: 9867026
[No Abstract] [Full Text] [Related]
42. Cyclooxygenase-1 and -2 isoenzymes.
Hla T; Bishop-Bailey D; Liu CH; Schaefers HJ; Trifan OC
Int J Biochem Cell Biol; 1999 May; 31(5):551-7. PubMed ID: 10399316
[TBL] [Abstract][Full Text] [Related]
43. Prostaglandin endoperoxide synthases-1 and -2.
Otto JC; Smith WL
J Lipid Mediat Cell Signal; 1995 Oct; 12(2-3):139-56. PubMed ID: 8777562
[No Abstract] [Full Text] [Related]
44. Picture story. COX complexes.
Feng H
Nat Struct Biol; 2000 Jun; 7(6):448. PubMed ID: 10881188
[No Abstract] [Full Text] [Related]
45. Is cyclooxygenase-2 the alpha and the omega in cancer?
Prescott SM
J Clin Invest; 2000 Jun; 105(11):1511-3. PubMed ID: 10841506
[No Abstract] [Full Text] [Related]
46. Structural characterization of a pentadienyl radical intermediate formed during catalysis by prostaglandin H synthase-2.
Peng S; Okeley NM; Tsai AL; Wu G; Kulmacz RJ; van der Donk WA
J Am Chem Soc; 2001 Apr; 123(15):3609-10. PubMed ID: 11472139
[No Abstract] [Full Text] [Related]
47. COX-2 in cancer--a player that's defining the rules.
Hawk ET; Viner JL; Dannenberg A; DuBois RN
J Natl Cancer Inst; 2002 Apr; 94(8):545-6. PubMed ID: 11959883
[No Abstract] [Full Text] [Related]
48. COX-2 and cancer: a new approach to an old problem.
Bakhle YS
Br J Pharmacol; 2001 Nov; 134(6):1137-50. PubMed ID: 11704632
[No Abstract] [Full Text] [Related]
49. [Prostaglandin/bradykinin].
Hirawa N; Umemura S
Nihon Rinsho; 2004 Jun; 62 Suppl 6():183-8. PubMed ID: 15250292
[No Abstract] [Full Text] [Related]
50. Macula densa signalling--a potential role of cyclooxygenase-2 (COX-2)?
Harris RC
Nephrol Dial Transplant; 2000 Oct; 15(10):1504-6. PubMed ID: 11007811
[No Abstract] [Full Text] [Related]
51. Deciphering the physiological roles of COX-2.
Ehmke H; Kurtz A
Am J Physiol Regul Integr Comp Physiol; 2003 Feb; 284(2):R486-7. PubMed ID: 12529286
[No Abstract] [Full Text] [Related]
52. [Colon cancer and COX-2].
Ota S; Bamba H; Imai Y; Arai S; Fujiwara K
Nihon Shokakibyo Gakkai Zasshi; 2002 Mar; 99(3):253-63. PubMed ID: 11925862
[No Abstract] [Full Text] [Related]
53. Prostaglandins, COX-2, and sensory perception.
McCarthy D
Gut; 2000 Dec; 47 Suppl 4(Suppl 4):iv66-8; discussion iv76. PubMed ID: 11076921
[No Abstract] [Full Text] [Related]
54. The molecular perspective: cyclooxygenase-2.
Goodsell DS
Oncologist; 2000; 5(2):169-71. PubMed ID: 10794808
[No Abstract] [Full Text] [Related]
55. Physiologic characteristics and clinical importance of the cyclooxygenase isoforms in dogs and cats.
Jones CJ; Budsberg SC
J Am Vet Med Assoc; 2000 Sep; 217(5):721-9. PubMed ID: 10976307
[No Abstract] [Full Text] [Related]
56. COX-2 as a multifunctional neuronal modulator.
Bazan NG
Nat Med; 2001 Apr; 7(4):414-5. PubMed ID: 11283664
[No Abstract] [Full Text] [Related]
57. Cyclooxygenase-2 polymorphism: putting a brake on the inflammatory response to vascular injury?
Cipollone F; Patrono C
Arterioscler Thromb Vasc Biol; 2002 Oct; 22(10):1516-8. PubMed ID: 12377724
[No Abstract] [Full Text] [Related]
58. [Cyclooxygenase activity in chronic gastritis].
Sakamoto C
Nihon Shokakibyo Gakkai Zasshi; 2000 Dec; 97(12):1466-71. PubMed ID: 11193491
[No Abstract] [Full Text] [Related]
59. Unresolved issues in the role of cyclooxygenase-2 in normal physiologic processes and disease.
Lipsky PE; Brooks P; Crofford LJ; DuBois R; Graham D; Simon LS; van de Putte LB; Abramson SB
Arch Intern Med; 2000 Apr; 160(7):913-20. PubMed ID: 10761955
[TBL] [Abstract][Full Text] [Related]
60. [Selective cyclooxygenase-2 (COX-2) inhibitor. Progress in rheumatoid therapy?].
Reuss-Borst M
Internist (Berl); 1997 Mar; 38(3):266-71. PubMed ID: 9173052
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
